Introduction:

Forteen years ago, this group of researchers published the effects of surgical treatment of chronic osteomyelitis. They are currently presenting the results of the follow-up of the patients treated at that time.

Objectives:

To report the evolution and current clinical status of the patients implanted with HAP-200® porous hydroxyapatite 14 years ago.

Case report:

In 2024, the clinical and radiological status of four of the six patients who underwent surgical treatment with filling in the osteomyelitic cavity with HAP-200® porous hydroxyapatite was evaluated retrospectively, according to the methodology of the Cierny-Mader classification system. Out of the six patients, two had recurrences during the first year of follow-up and one of them requested amputation of the leg. The rest, to date, have not reported problems related to the disease.

Conclusions:

Cavity filling in chronic osteomyelitis with porous hydroxyapatite HAP-200® is considered an alternative surgical method for the orthopedic surgeon.

        · resumen en Español     · texto en Español     · Español ( pdf )